-
Science｜Li Jing et al. discovered and identified CD8+ T cell subsets with regulatory functions in the human body
Time of Update: 2022-06-19
In conclusion, the authors discovered and identified a new subset of CD8+ T cells with regulatory functions in humans, which can selectively suppress pathogenic T cells that trigger autoimmune responses, thereby contributing to the maintenance of peripheral immune tolerance.
-
Chemotherapy drug-allergic ALL patients new hope Eryaspas can be used for second-line treatment
Time of Update: 2022-06-18
In the NOPHO ALL2008 regimen, 5 doses of PEG-asparaginase (1000 IU/m²/dose, intramuscularly) were administered to non-high-risk patients at 2-week intervals during the consolidation phase, starting on day 30 of treatment, followed by delayed intensive chemotherapy.
-
The cold box of the main body of Yanshan Petrochemical Liquid Air’s newly-built nitrogen production unit was successfully hoisted
Time of Update: 2022-06-18
>, Yanshan Petrochemical Air Liquide Company's newly-built nitrogen production unit (TCN) was successfully hoisted, and the main equipment cold box
-
Nature Immunol type I cytokines cooperate to promote the body's inflammatory response
Time of Update: 2022-06-18
These data suggest that during the progression of chronic neuroinflammation, the MTPT process occurs in the central nervous system, and classical monocytes with high Ly6C expression accumulate at the site of inflammation through terminally differentiated inflammatory macrophages .
-
Honeywell's new intelligent storage equipment production line in China is officially put into operation
Time of Update: 2022-06-16
The Honeywell pallet stacker production line put into production at the Suzhou plant this time can greatly shorten the equipment supply cycle and ensure that customers can put it into use at the first time.
-
Authoritative experts commented that YESCARTA® was first approved by the FDA for second-line LBCL treatment, a milestone new progress in CAR-T therapy!
Time of Update: 2022-06-16
months of first-line therapy sex and effectiveness . A total of 359 patients were enrolled in the study, with a median follow-up of 24. 9 months, Axi-cel showed
-
Visible foreign body inspection of Qingkailing injection and Shuanghuanglian for injection (lyophilized)
Time of Update: 2022-06-15
Conclusion: meet the regulationsInspection of visible foreign body of Shuanghuanglian for injection (lyophilized)test recordIllumination: -3000lxSpecification: 600mg eachResults: After 5 test samples (bottles) were dissolved in 10ml sterile water for injection, no visible foreign matter was detected .
-
LANCET: The dual benefits of "lowering blood pressure + preventing diabetes", these two drugs may be the first-line choice for prediabetes blood pressure
Time of Update: 2022-06-15
However, the researchers believe: "Whether the reduction in diabetes risk is due to the lowering of blood pressure itself or the effect of antihypertensive drugs is not yet conclusive .
-
Ponatinib combined with steroid first-line therapy is promising in elderly and unfit patients with Ph+ acute lymphoblastic leukemia
Time of Update: 2022-06-14
Studies have shown that imatinib combined with steroid induction therapy, followed by imatinib combined with chemotherapy and stem cell transplantation (SCT), can achieve an overall survival (OS) rate of 49% and 5-year disease-free survival in adult patients with Ph+ ALL.
-
How to do the installation and maintenance of the vial liquid filling production line
Time of Update: 2022-06-14
Vial bottle liquid filling production line When the tooth plate is moved to move the bottle to the position of the stopper tooth for filling the liquid medicine, the convex surface of the cam 7 is separated from
-
Your baby's birth weight is linked to lifetime diabetes risk -- the lower your body weight, the sooner you may develop type 2 diabetes
Time of Update: 2022-06-13
Lower birth weight may be associated with lower age at onset of type 2 diabetes and BMI at diagnosis, according to a study published in the journal Diabetes Medicine .
-
Advantages and daily maintenance of disinfectant filling production line
Time of Update: 2022-06-11
The disinfectant filling production line developed by Shanghai Shenggang is a fully functional automatic equipment .
-
New dawn for first-line treatment of esophageal cancer!
Time of Update: 2022-06-06
, its first-line treatment has made little progress in the past 40 years or so . Now, this situation may usher in a major turning point
-
Express first-line treatment of liver cancer, anti-CTLA-4/PD-L1 antibody combination entered priority review
Time of Update: 2022-06-04
It was used in combination with Imfinzi and chemotherapy to significantly improve patients' overall survival in a Phase 3 clinical trial in first-line treatment of stage IV non-small cell lung cancer .
-
"14th Five-Year Plan" renewable energy is expected to become the main body of energy consumption increase
Time of Update: 2022-06-03
-carbon transition of energy production and consumption, Xi Guofu suggests to do the following three aspects. The first is to establish a new energy consumption market mechanism for the national power
-
Sintilimab is included in the guidelines of the Chinese Society of Clinical Oncology (CSCO) for the first-line treatment of five major tumor types
Time of Update: 2022-05-31
of sintilimab has been accepted and reviewed by the China National Medical Products Administration (NMPA) for three indications, including: Combination of cisplatin and paclitaxel/cisplatin and 5-fluorouracil for advanced or metastatic esophageal squamous
-
MET amplification resistance in patients with EGFR-mutant advanced lung cancer after multi-line therapy?
Time of Update: 2022-05-31
, consider: brain metastasis . Genetic testing: EGFR exon 19 deletion mutation . Diagnosis: right lung
-
Express first-line treatment of esophageal cancer, BeiGene/Novartis PD-1 antibody combination
Time of Update: 2022-05-31
treatment of advanced stage or met the primary endpoint in a phase 3 clinical trial in patients with metastatic esophageal squamous cell carcinoma (ESCC) . An interim analysis
-
"Science": Enterobacteria directly regulate host appetite and body temperature!
Time of Update: 2022-05-29
in the mouse brain [3], and where these cell wall peptides are sent from and what they are sent to the brain for, the case has not yet been closed . But everyone agrees
-
AstraZeneca/Daisankyo's blockbuster ADC received FDA approval for express second-line treatment of breast cancer
Time of Update: 2022-05-27
In this trial, Enhertu reduced the risk of disease progression or death by 72% in patients with HER2-positive unresectable and/or metastatic breast cancer previously treated with trastuzumab and a taxane compared with the active control group ([ HR]=0.
